These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 37629039)
41. Ferroptosis: A Potential Therapeutic Target in Acute Kidney Injury. Hosohata K; Harnsirikarn T; Chokesuwattanaskul S Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743026 [TBL] [Abstract][Full Text] [Related]
42. Puerarin Protects against Myocardial Ischemia/Reperfusion Injury by Inhibiting Ferroptosis. Ding Y; Li W; Peng S; Zhou G; Chen S; Wei Y; Xu J; Gu H; Li J; Liu S; Liu B Biol Pharm Bull; 2023 Apr; 46(4):524-532. PubMed ID: 36696989 [TBL] [Abstract][Full Text] [Related]
43. Plasma exosomes from patients with acute myocardial infarction alleviate myocardial injury by inhibiting ferroptosis through miR-26b-5p/SLC7A11 axis. Li H; Ding J; Liu W; Wang X; Feng Y; Guan H; Chen Z Life Sci; 2023 Jun; 322():121649. PubMed ID: 37011873 [TBL] [Abstract][Full Text] [Related]
44. Resveratrol protects against myocardial ischemia-reperfusion injury via attenuating ferroptosis. Li T; Tan Y; Ouyang S; He J; Liu L Gene; 2022 Jan; 808():145968. PubMed ID: 34530090 [TBL] [Abstract][Full Text] [Related]
45. The reduction of infarct size--forty years of research. Ferreira R Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114 [TBL] [Abstract][Full Text] [Related]
46. Regulation of metabolism by mitochondrial enzyme acetylation in cardiac ischemia-reperfusion injury. Herr DJ; Singh T; Dhammu T; Menick DR Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165728. PubMed ID: 32068115 [TBL] [Abstract][Full Text] [Related]
48. Metabolic derangement in ischemic heart disease and its therapeutic control. Ferrari R; Pepi P; Ferrari F; Nesta F; Benigno M; Visioli O Am J Cardiol; 1998 Sep; 82(5A):2K-13K. PubMed ID: 9737480 [TBL] [Abstract][Full Text] [Related]
49. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?]. Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337 [TBL] [Abstract][Full Text] [Related]
50. Ferroptosis Inhibitors as Potential New Therapeutic Targets for Cardiovascular Disease. Shaghaghi Z; Motieian S; Alvandi M; Yazdi A; Asadzadeh B; Farzipour S; Abbasi S Mini Rev Med Chem; 2022; 22(17):2271-2286. PubMed ID: 35184711 [TBL] [Abstract][Full Text] [Related]
51. Role of iron homeostasis in the heart : Heart failure, cardiomyopathy, and ischemia-reperfusion injury. Ying H; Shen Z; Wang J; Zhou B Herz; 2022 Apr; 47(2):141-149. PubMed ID: 33978777 [TBL] [Abstract][Full Text] [Related]
52. Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future. Fang W; Xie S; Deng W Cell Biol Toxicol; 2024 Mar; 40(1):17. PubMed ID: 38509409 [TBL] [Abstract][Full Text] [Related]
53. The role of ferroptosis in cell-to-cell propagation of cell death initiated from focal injury in cardiomyocytes. Kawasaki NK; Suhara T; Komai K; Shimada BK; Yorichika N; Kobayashi M; Baba Y; Higa JK; Matsui T Life Sci; 2023 Nov; 332():122113. PubMed ID: 37739163 [TBL] [Abstract][Full Text] [Related]
54. Targeting Ferroptosis as a Promising Therapeutic Strategy for Ischemia-Reperfusion Injury. Pan Y; Wang X; Liu X; Shen L; Chen Q; Shu Q Antioxidants (Basel); 2022 Nov; 11(11):. PubMed ID: 36358568 [TBL] [Abstract][Full Text] [Related]
55. Loureirin C inhibits ferroptosis after cerebral ischemia reperfusion through regulation of the Nrf2 pathway in mice. Liu Y; Mi Y; Wang Y; Meng Q; Xu L; Liu Y; Zhou D; Wang Y; Liang D; Li W; Li N; Hou Y Phytomedicine; 2023 May; 113():154729. PubMed ID: 36878093 [TBL] [Abstract][Full Text] [Related]
56. Novel Findings and Therapeutic Targets on Cardioprotection of Ischemia/ Reperfusion Injury in STEMI. Li J; Sun D; Li Y Curr Pharm Des; 2019; 25(35):3726-3739. PubMed ID: 31692431 [TBL] [Abstract][Full Text] [Related]
57. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion. Li Y; Feng D; Wang Z; Zhao Y; Sun R; Tian D; Liu D; Zhang F; Ning S; Yao J; Tian X Cell Death Differ; 2019 Nov; 26(11):2284-2299. PubMed ID: 30737476 [TBL] [Abstract][Full Text] [Related]
58. Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury. Li Y; Cao Y; Xiao J; Shang J; Tan Q; Ping F; Huang W; Wu F; Zhang H; Zhang X Cell Death Differ; 2020 Sep; 27(9):2635-2650. PubMed ID: 32203170 [TBL] [Abstract][Full Text] [Related]
59. Myocardial ischemia/reperfusion injury: Mechanisms of injury and implications for management (Review). He J; Liu D; Zhao L; Zhou D; Rong J; Zhang L; Xia Z Exp Ther Med; 2022 Jun; 23(6):430. PubMed ID: 35607376 [TBL] [Abstract][Full Text] [Related]
60. Ferroptosis as a target for protection against cardiomyopathy. Fang X; Wang H; Han D; Xie E; Yang X; Wei J; Gu S; Gao F; Zhu N; Yin X; Cheng Q; Zhang P; Dai W; Chen J; Yang F; Yang HT; Linkermann A; Gu W; Min J; Wang F Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2672-2680. PubMed ID: 30692261 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]